Clinical trials
Not yet recruiting Phase 1 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 8 |
| GlaxoSmithKline | 2 |
| Qilu Pharmaceutical Co., Ltd. | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Xuzhou Medical University | 2 |
| Zhejiang University | 2 |
| BrightPath Biotherapeutics Co., Ltd. | 1 |
| Canadian Myeloma Research Group | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Carbiogene Therapeutics Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 39 |
| Recurrence | 5 |
| Leukemia, Plasma Cell | 2 |
| Amyloidosis | 1 |
| Burkitt Lymphoma | 1 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Leukemia, Hairy Cell | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lymphoma | 1 |
| Lymphoma, B-Cell | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.